Cystoscopy.
Conditions
Interventions
Intervention 1: Intervention group: First, midazolam was injected 0.03 mg / kg, fentanyl 2µ /kg intravenously, then patients in the Diphenhydramine group received 0.6 mg / kg diphenhydramine intraven
Sponsors
Deputy of Research,Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: male patient Age 20 to 75 years old Cystoscopy candidate ASA Class 1 and 2 No allergy to used drugs No history of cardio-pulmonary-liver and kidney disease Lack of Obstructive Sleep Apnea (OSA) No history of drug addiction or other psychotropic substances No history of acute drug or alcohol poisoning No history of psychological illness
Exclusion criteria
Exclusion criteria: History of closed glaucoma History of dry mouth disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of Cystoscopy. Timepoint: Once .Start and end of Cystoscopy. Method of measurement: With stopwatch.;Mean Arterial Blood Pressure. Timepoint: Before the cystoscope enters the urethra and bladder, 30 seconds after entering the urethra, then every 2 minutes. Method of measurement: Non-invasive and automatically.;Heart Rate. Timepoint: Before the cystoscope enters the urethra and bladder, 30 seconds after entering the urethra, then every 2 minutes. Method of measurement: from monitor.;The amount of propofol consumed. Timepoint: Once at the end of cystoscopy. Method of measurement: In milligrams.;Patient response when a cystoscope enters the urethra. Timepoint: When the cystoscope enters the urethra. Method of measurement: Observe the patient's movements and rate it from 0-3 according to the type of movements.;Pain intensity. Timepoint: During cystoscopy and in recovery. Method of measurement: visual analog scale (VAS).;Quality and satisfaction of the surgeon from Sedition. Timepoint: At the end of cystoscopy. Method of measurement: Ask the surgeon and score from 1-4.;Quality and patient satisfaction from sedation. Timepoint: in recovery room. Method of measurement: Ask the patients and score from 1-4. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Khajavi
Tehran University of Medical Sciences
Outcome results
None listed